Dementia with Lewy bodies
https://doi.org/10.31363/2313-7053-2018-2-11-21
Abstract
Te lecture presents modern concept of the symptoms, diagnosis and treatment of dementia with Lewy bodies (DLB), which accounts for about 10% of cases of dementia. Te nosological status of DLB and the problem of ratio of DLB and Parkinson’s disease which, apparently, represent two phenotypic variants of one neurodegenerative process («diseases with Lewy bodies») are considered in historical aspect. Approaches to the diagnosis and coding of DLB in accordance with ICD-10 are proposed. Te role of cholinesterase inhibitors, antipsychotics, levodopa, rasagiline and other drugs in the treatment of patients with DLB is аnalyzed.
About the Authors
O. S. Levin
Russian medical Academy of continuous professional education
Russian Federation
Russian Federation
E. E. Vasenina
Russian medical Academy of continuous professional education
Russian Federation
Russian Federation
A. Sh. Chimagomedova
Russian medical Academy of continuous professional education
Russian Federation
Russian Federation
N. G. Dudchenko
Russian medical Academy of continuous professional education
Russian Federation
Russian Federation
References
1. Гаврилова С.И. Фармакотерапия болезни Альцгеймера. — М. — 2013. — 319с.
2. Левин О.С. Болезнь диффузных телец Леви // Экстрапирамидные расстройства. Руководство по диагностике и лечению. Под ред. В.Н. Штока, И.А. Ивановой — Смоленской, О.С. Левина. — М.: Медпресс-информ. — 2002. — С. 233-256.
3. Левин О.С Эффективность реминила при деменции с тельцами Леви. — Журнал неврологии и психиатрии им. Корсакова. — 2005. — №10. — С.10-15.
4. Левин О.С.: Деменция с тельцами Леви. Практические вопросы диагностики и лечения. — Москва. — 2006. — 66с.
5. Левин О.С., Амосова Н.А., Наймушина Т.В., Смоленцева И.Г. Сравнительное клиниконейропсихологическое исследование больных болезнью Паркинсона и деменцией с тельцами Леви. — Журнал неврологии и психиатрии им. Корсакова. — 2004. — №1 — С.37-42.
6. Левин О. С. , Батукаева Л. А. Смоленцева И. Г. Амосова Н. А. Эффективность и безопасность мемантина при деменции с тельцами Леви. — Журнал неврологии и психиатрии им. Корсакова. — 2008. — №5. — С.37-42.
7. Левин О. С. , Аникина М. А. , Шиндряева Н.Н., Зимнякова О. С. Психотические нарушения при болезни Паркинсона и деменции с тельцами Леви. — Журнал неврологии и психиатрии им. С.С. Корсакова. — 2011. — № 6. — С.82-88.
8. Левин О.С., Васенина Е.Е., Аникина М.А., Макотрова Т.А. Деменция с тельцами Леви // Журн неврол и психиат. — 2012. — №10. — С.3-12.
9. Преображенская И.С., Яхно Н.Н. Деменция с тельцами Леви. — Неврологический журнал. — 2003. — №6. — С.4-11.
10. Чимагомедова А.Ш., Васенина Е.Е., Левин О.С. Диагностика деменции с тельцами Леви на продромальной стадии // Журн неврол и психиат. — 2017. — №6. — С. 23-32.
11. Aarsland D., Ballard C., Rongve A. Clinical Trials of Dementia With Lewy Bodies and Parkinson’s Disease Dementia. — Curr Neurol Neurosci Rep. — 2012. — DOI 10.1007/s11910-012-0290-7
12. Braak H., Rüb U.,. Jansen Steur E.N.H, et al.Cognitive status correlates with neuropathologic stage in Parkinson disease. — Neurology. — 2005. — Vol.64. — P.1404-1410.
13. DSM-5: Te Future of Psychiatric Diagnosis .http:// www.dsm5.org
14. Edwards K; Royall D; Hershey L; et al. Efcacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.—Dement Geriatr Cogn Disord. – 2007.—Vol.23.—P.401-405.
15. Emre M; Tsolaki M; Bonuccelli U; et al. Memantine for patients with Parkinson’s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. — Lancet Neurol. – 2010. — Vol.9. — P.969-977.
16. Fujishiro H., Nakamura S., Sato K., Iseki E. Prodromal dementia with Lewy bodies // Geriatr Gerontol Int. — 2015. — V.15. — P. 817-826.
17. Gomez-Tortosa E., Newell K., Irizarry M.C., et al. Clinical and quantitative pathologic correlates of dementia with Lewy bodies. — Neurology. — 1999. — Vol.53. — P.1284-1291.
18. Graff-Radford J., Boeve F, Pedraza O. et al.Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies. — Brain. — 2012. — doi:10.1093/brain/aws173
19. Halliday G, McCann H. Te progression of pathology in Parkinson’s disease Ann. — N.Y. Acad. Sci. — 2010. — Vol.1184. — P.188–195.
20. Klein JC, Eggers C, Kalbe E, et al. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. — Neurology. — 2010. — Vol.74. — P.885–892.
21. Kosaka K. Dementia and neuropathology in Lewy body disease. — Adv Neurol. — 1993. — Vol.60. — P.456-463.
22. Kotzbauer P. T., Cairns N. J., Campbell Meghan C. et al. Pathologic Accumulation of _-Synuclein and Ain Parkinson Disease Patients With Dementia // Arch Neurol. — 2012. — doi:10.1001/archneurol.2012.1608
23. McKeith IG, Galasko D, Kosaka K, et al: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies: report of the consortium on DLB workshop //Neurology. — 1996. — Vol.47. — P. 1113–1124.
24. McKeith IG, Del Ser T, Spano PF, et al. Efcacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. — Lancet. — 2000. — Vol.356. — P. 2031–2036.
25. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. — Neurology. — 2005. — Vol.65. — P. 1863–1872.
26. McKeith I., Taylor J., Tomas A., Donaghy P. and Kane J. Revisiting DLB Diagnosis: A Consideration of Prodromal DLB and of the Diagnostic Overlap With Alzheimer Disease // Journal of Geriatric Psychiatry and Neurology. — 2016. — V.29. — P. 249-253.
27. McKeith I., Boeve B.F., Dickson D.W. et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium // Neurology. — 2017. [Epub ahead of print]
28. McKeith I. DLB and PDD: the same or different? Is there a debate? — Int Psychogeriatr., — 2009. — V.21. — P. 220-224.
29. Rojas-Fernandez CH. Successful use of donepezil for the treatment of dementia with Lewy bodies. — Ann Pharmacother. — 2001. — Vol.35. — P. 202–205.
30. Tiraboschi P, Hansen LA, Alford M, et al. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. — Arch Gen Psychiatry. — 2002. — Vvol.59. — P. 946–951.
Review
For citations:
Levin O.S., Vasenina E.E., Chimagomedova A.Sh., Dudchenko N.G. Dementia with Lewy bodies. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2018;(2):11-21. (In Russ.) https://doi.org/10.31363/2313-7053-2018-2-11-21
Views:
2386
Email this article 